MISCAN-PRO (Erasmus)

MIcrosimulation SCreening Analysis (MISCAN) Prostate Cancer Model

Basic Model Attributes
Cancer siteProstate
Host institution Erasmus University Medical Center
Purpose The MISCAN simulation model has been developed for estimating the effect of prostate cancer screening in a dymamic population, to explain results of prostate cancer screening trials and to predict and compare the cost-effectiveness of different screening policies. Also, the model can be used to estimate unobservable processes and variables (such as the natural history of the disease, overdiagnosis and lead time).
Contact Eveline Heijnsdijk (e.heijnsdijk@erasmusmc.nl)